Antiprotozoals: Nursing pharmacology

Antiprotozoals: Nursing pharmacology

nclex review

nclex review

Diabetes insipidus: Nursing process (ADPIE)
Diabetes insipidus and SIADH: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Psoriasis: Nursing
Psoriasis
Psoriatic arthritis
Respiratory acidosis
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical
Respiratory distress syndrome: Pathology review
Metabolic acidosis
Acid-base map and compensatory mechanisms
Vaccinations
Pediatric infectious rashes: Clinical
Vaccinations: Clinical
Mumps virus
Measles virus
Chickenpox (Varicella): Nursing process (ADPIE)
Varicella zoster virus
Bordetella pertussis (Whooping cough)
Erythema multiforme
Parvovirus B19
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Clinical
Systemic lupus erythematosus (SLE): Pathology review
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Movement of water between body compartments
Hyponatremia: Clinical
Necrotizing enterocolitis
Short bowel syndrome (NORD)
Hyperkalemia
Hyperkalemia: Clinical
Potassium homeostasis
Plasma anion gap
Autoimmune polyglandular syndrome type 1 (NORD)
Mycobacterium tuberculosis (Tuberculosis)
Leukodystrophy
Cholesterol metabolism
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Liver anatomy and physiology
Medications for thyroid disorders: Nursing pharmacology
Thyroid storm
Hypothyroidism and thyroiditis: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Thyroid hormones
Erysipelas and cellulitis: Nursing
Staphylococcus epidermidis
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Major depressive disorder
Antipsychotics: Nursing pharmacology
Delirium
Medications to control airway secretions: Nursing pharmacology
Rhinovirus
Bites and stings: Clinical
Sickle cell disease (NORD)
Sickle cell disease: Nursing process (ADPIE)
Chronic kidney disease (CKD): Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Kidney stones: Pathology review
Chronic kidney disease: Clinical
Acute kidney injury: Clinical
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Tonsillitis: Nursing process (ADPIE)
Epstein-Barr virus (Infectious mononucleosis)
Adenovirus
Calcium-channel blockers: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Phosphate, calcium and magnesium homeostasis
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Oxytocin: Nursing pharmacology
Nitrates: Nursing pharmacology
Vaccines: Nursing pharmacology
Antiemetics: Nursing pharmacology
Insulin: Nursing pharmacology
Hemostatics: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antacids: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antihistamines: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Biologic agents: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Tocolytics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Blood products: Nursing pharmacology
Graves disease
Hirschsprung disease

Notes

ANTIPROTOZOALS
DRUG NAME
atovaquone (Mepron), tinidazole (Tindamax), pyrimethamine (Daraprim), benznidazole (Rochagan, Radanil), nitazoxanide, pentamidine (NebuPent)
CLASS
Antiprotozoals
MECHANISM OF ACTION
Block DNA synthesis in protozoa → prevent reproduction → death
INDICATIONS
Protozoan infections (e.g., giardiasis, trichomoniasis, intestinal amebiasis)
ROUTE(S) OF ADMINISTRATION
  • PO (atovaquone, tinidazole, pyrimethamine, benznidazole, nitazoxanide)
  • IV (pentamidine)
  • IM (pentamidine)
  • INH - nebulizer (pentamidine)
SIDE EFFECTS
  • Headaches, dizziness, peripheral neuropathy, ataxia, loss of coordination
  • Skin rash, urticaria
  • Gastrointestinal disturbances (e.g., unpleasant mouth taste, nausea, vomiting, diarrhea, cramping)
  • Disrupt intestinal flora → bacterial or fungal superinfections
  • Hematologic abnormalities (e.g., leukopenia, anemia, thrombocytopenia)
  • Tinidazole: Boxed warning: malignancy
CONTRAINDICATIONS AND CAUTIONS
  • Pregnancy and breastfeeding
  • Children and elderly clients
  • Hematologic disorders
  • Central nervous system disorders
  • Cardiac, hepatic, or renal disease
  • Alcohol use
NURSING CONSIDERATIONS: ANTIPROTOZOALS
ASSESSMENT AND MONITORING
Assessment
  • Symptoms of infection; e.g., fatigue, stomach pain and cramping, stool characteristics and frequency, signs of dehydration
  • Laboratory test results: liver function tests, stool culture, DFA

Monitoring
  • Stool culture results
  • Side effects
  • Therapeutic effect of infection resolution
CLIENT EDUCATION
  • Purpose of medication: helps resolve their infection and shorten contagious time
  • Take medication once daily with food
  • Avoid alcohol during treatment and for three days after treatment is complete
  • Common side effects; e.g., headaches, unpleasant taste
  • Notify healthcare provider:
    • Dizziness, peripheral neuropathy
    • Signs of superinfection
  • Resolution of infection takes a few weeks
    • Stool is infectious until they receive a negative stool culture result
    • Precautions to avoid infecting others
      • Wash their hands with soap and water frequently; after using the bathroom; before preparing food or eating
      • Avoid swimming in pools, hot tubs, lakes, rivers, and the ocean until one week after the tinidazole course is complete
  • Prevention of future infections
    • Avoid swallowing water from swimming pools, hot tubs and splash pads
    • Pretreat drinking water when camping or traveling
Author: Antonia Syrnioti, MD
Author: Ashley Mauldin, MSN, APRN, FNP-BC
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antiprotozoals are a group of medications used to treat protozoal infections, such as giardiasis, trichomoniasis, or intestinal amebiasis.

The most commonly used antiprotozoals are atovaquone, tinidazole, benznidazole, pyrimethamine, and nitazoxanide, which can be taken orally; as well as pentamidine that can be administered by nebulizer, intramuscularly, or intravenously.

Once administered, antiprotozoals act on protozoa by blocking DNA synthesis, preventing them from reproducing, and ultimately killing them.

Side effects typically include headaches, dizziness, peripheral neuropathy, ataxia, and loss of coordination. Some clients may also develop a skin rash or urticaria.

In addition, antiprotozoals may often cause gastrointestinal disturbances, such as an unpleasant mouth taste, nausea, vomiting, diarrhea, and cramping.

Moreover, these medications can disrupt the normal intestinal flora, so clients might develop bacterial or fungal superinfections.

Finally, some of these medications can be associated with hematologic abnormalities, such as leukopenia, anemia, or thrombocytopenia; while tinidazole has a boxed warning for increasing the risk of developing malignancy.

Now, antiprotozoals are contraindicated during pregnancy and breastfeeding, while precautions should be taken with children and elderly clients.

In addition, these medications should also be used with caution in clients with hematologic or central nervous system disorders, as well as in those with cardiac, renal, or hepatic disease, and alcoholic beverages should be avoided.

Okay, when caring for a client with giardiasis who has been prescribed tinidazole, first obtain a baseline of your client’s symptoms, such as fatigue, stomach pain and cramping, as well as stool characteristics and frequency.

Then, assess for signs of dehydration, such as decreased urine output, dark yellow urine, or decreased skin turgor.

Lastly, review their most recent laboratory test results, including liver function tests, as well as stool culture and microscopy with direct fluorescent antibody testing, or DFA results.

Now, before your client begins treatment with an antiprotozoal like tinidazole, explain how their medication will help to resolve the infection and shorten the time they’re contagious, and remind them that their symptoms may take a few weeks to resolve.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens" Infect Dis Clin North Am (2019)
  6. "Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain" Pathogens (2021)
  7. "A new effective antiplasmodial compound: Nanoformulated pyrimethamine" J Glob Antimicrob Resist (2020)
  8. "Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors" ACS Med Chem Lett (2021)